脑脊髓液 (CSF) 管理 - 全球市场回顾、竞争格局、市场预测 (2030)

预计 2024 年至 2030 年预测期内，全球脑脊髓液 (CSF) 管理市场规模将以 4.78% 的复合年增长率成长。 由于事故和创伤数量增加、脑肿瘤盛行率增加、儿童脑积水盛行率增加、对先进技术产品的需求增加以及老年人口的增加，对脑脊髓液（CSF）管理的需求增加，预计将推动产品需求在全球脑脊髓液（CSF）管理市场。

脑脊髓液 (CSF) 管理的市场动态

由于脑肿瘤盛行率上升，脑脊髓液 (CSF) 管理市场的市场收入增加。 脑肿瘤与脑脊髓液在大脑中的积聚有关，最终导致大脑内颅内压升高。 根据国际癌症研究机构 2020 年发布的 GLOBOCAN 研究，2020 年全球脑肿瘤病例为 308,102 例。 过多的液体会给大脑带来压力并导致脑损伤。 因此，采用脑脊髓液分流器和引流系统等脑脊髓液管理装置来避免脑部积液。 因此，全球脑肿瘤的增加预计将增加对脑脊髓液管理设备的需求，从而导致全球脑脊髓液管理市场的成长。

道路事故造成的伤害增加也被认为是脑脊髓液管理设备市场的主要成长因素之一。 根据世界卫生组织 (WHO) 道路交通伤害情况说明书 (2023)，道路交通伤害是全球 5 至 29 岁儿童和年轻人死亡的主要原因。 情况说明书进一步指出，大约 2,000 万至近 5,000 万人因道路交通事故遭受非致命伤害，并因此留下残疾。 这种性质的伤害可能导致严重的头部外伤。 结果，大脑中可能形成血块并限制脑脊髓液在大脑内的流动。 结果，脑脊髓液在大脑中积聚，并在脑脊髓液管理设备的帮助下进行治疗。 因此，道路事故和伤害的增加预计将导致对脑脊髓液（CSF）管理设备的需求增加，进而推动预测期内的全球脑脊髓液（CSF）管理市场。

然而，严格的产品审批流程以及与设备相关的常见风险（例如感染、分流功能障碍和引流不当）仍然是脑脊髓液（CSF）管理市场成长的某些限制因素。

除上述因素外，由于为遏制 COVID-19 传播而实施的全国范围内的封锁等必要措施，全球脑脊髓液 (CSF) 管理市场遭受了暂时的挫折。曾经有一段时间。 这段时间的主要措施之一是暂停许多择期手术和门诊。 这导致各科室大量手术以非必要为由暂停，部分重症监护室因封城初期患者人数减少而关闭，导致脑脊髓液供应量下降市场上管理设备的需求减少，从而在短时间内限制了市场的增长。 然而，由于世界各地多种 COVID-19 疫苗的批准和管理，脑脊髓液 (CSF) 管理设备市场正在经历一段復苏期，包括医疗保健服务在内的各个领域都已恢復活动。

脑脊髓液（CSF）管理细分市场分析

在 CSF 管理市场的产品领域，CSF 分流器和阀门预计将在预测期内占据市场的主要收入份额。 它最常用于因脑室内出血或脊柱裂导致的脑积水/液体滞留的儿科患者，其在脑积水治疗中的应用极大地改善了与这些疾病相关的临床结果。这可能是由于可能性。 此外，与其他脑脊髓液管理设备相比，它旨在终身使用，从而提供更持久的治疗方法。

此外，产品开发方面的技术进步，例如开发具有避免脑脊髓液过度引流的电子（外部）可编程组件的新型特技，也可能对脑脊髓液管理市场对该产品类型的需求产生积极影响。成为一个促成因素。

本报告提供了全球脑脊髓液 (CSF) 管理市场的研究和分析，包括市场规模和预测、驱动因素和挑战以及公司和产品概况。

目录

第1章脑脊髓液 (CSF) 管理市场报告简介

第 2 章脑脊髓液 (CSF) 管理市场执行摘要

• 调查范围
• 市场概览
• 竞争评估
• 财务基准

第3章监理与专利分析

• 美国
• 欧洲
• 日本
• 中国

第4章脑脊髓液（CSF）管理市场关键因素分析

• 脑脊髓液 (CSF) 管理市场驱动因素
  • 脑积水盛行率增加
  • 受伤和事故数量不断增加
  • 脑肿瘤盛行率不断上升
  • 更重视创新产品开发
• 脑脊髓液 (CSF) 管理市场的限制和挑战
  • 与设备相关的风险
  • 严格的产品审批流程
• 脑脊髓液 (CSF) 管理市场机遇
  • 开发具有抗菌性能的设备
  • 提高产品安全性

第5章脑脊髓液 (CSF) 管理市场的波特五力分析

第6章 COVID-19 对脑脊髓液 (CSF) 管理市场的影响分析

第7章脑脊髓液（CSF）管理市场布局

• 依产品类型
  • 脑脊髓液分流器、阀门
  • 体外引流系统
  • 防虹吸装置
  • 其他
• 依年龄段
  • 成人
  • 儿童
• 按最终用户
  • 医院
  • 专科诊所
• 按地区
  • 北美
  • 欧洲
  • 亚太地区
  • 其他领域

第 8 章脑脊髓液 (CSF) 管理市场：全球公司份额分析 - 3 至 5 家主要公司

第 9 章脑脊髓液 (CSF) 管理市场公司与产品概况

• Medtronic
• B. Braun Melsungen AG
• Neuromedex GmbH
• Natus Medical Incorporated
• Sophysa
• Integra LifeSciences Corporation
• Spiegelberg GmbH & Co. KG
• Desu Medical
• Polyganics
• CHRISTOPH MIETHKE GMBH & CO. KG
• HpBio Proteses Inc
• Wellong Instruments Co., Ltd.
• Moller Medical GmbH
• RAUMEDIC AG
• Anuncia Inc
• Vivonics Inc
• CereVasc Inc

第10章KOL观看次数

第 11 章专案方法

第 12 章关于 DelveInsight

第 13 章免责声明与联络资讯

Cerebrospinal Fluid Management Market By Product Type (Csf Shunts & Valves, External Drainage Systems [Drainage And Monitoring Systems, Drainage-Specific Systems, And Csf Drainage Catheters {Ventricular, Lumbar, And Others}], Anti-Siphon Devices, And Others), By Age Group (Adult And Pediatric), By End User (Hospitals And Specialty Clinics), by geography is expected to grow at a steady CAGR forecast till 2030 owing to the rising prevalence of hydrocephalus due to brain tumors and road accidents.

Global Cerebrospinal Fluid Management Market will grow at a CAGR of 4.78% during the forecast period from 2024 to 2030. The demand for CSF management is witnessing growth due to the rising number of accident and trauma cases, growing prevalence of brain tumors, increasing cases of childhood hydrocephalus, rising demand for technologically advanced products, and increasing geriatric population are expected to drive the product demand in the global CSF management market.

Cerebrospinal Fluid Management Market Dynamics:

The cerebrospinal fluid (CSF) management market is witnessing an increase in market revenue owing to the rising prevalence of brain tumors. Brain tumors are associated with the accumulation of CSF in the brain which ultimately result in the increase of the intracranial pressure inside the brain. As per the GLOBOCAN study published by the International Agency for Research on Cancer published in 2020, brain cancers accounted for 308,102 cases across the globe in 2020. The excess fluid puts pressure on the brain, which can damage it. Therefore, in order to avoid the fluid buildup inside the brain, CSF management devices such as CSF shunts and drainage systems are employed. Therefore, the rising global prevalence of brain tumors is expected to result in the growing demand for CSF management devices, thereby aiding in the global CSF management market growth.

Increasing cases of road traffic injuries can be considered as another key factor responsible for the growth of the CSF management devices market. According to the World Health Organization factsheet (2023) on road traffic injuries, injuries associated with road accidents are the leading cause of fatality in children and young adults belonging to the age group 5-29 years across the globe. The same factsheet further stated that near about 20-50 million people suffer from non-fatal injuries in road accidents resulting in a disability as a result of their injury. Injuries of this nature may result in severe head trauma. This may result in formation of blood clots inside the brain which may restrict the flow of CSF inside the brain. This in turn leads to the accumulation of CSF inside the brain, which in turn would be treated with the help of CSF management devices. Therefore, the increase in the cases of road traffic injuries and accidents is expected to contribute in the growing demand for cerebrospinal fluid management devices, eventually taking the global cerebrospinal fluid management market forward during the forecast period.

However, stringent product approval process, common risks associated with the devices such as infection, shunt malfunction, and improper drainage, among others may prove to be certain restraints to the CSF management market growth.

Along with the above-mentioned factors, the global cerebrospinal fluid management market witnessed a period of temporary setback as necessary measures to contain the COVID-19 spread were imposed such as country-wide lockdowns. One of the major steps during this was the suspension of numerous elective procedures and outpatient visits which reduced the demand for CSF management devices in the market as a large number of surgeries across different medical specialties were suspended on account of either being non-essential or several of intensive care units were closed because of the reduction in number of patient during the initial lockdown period, thereby limiting the market growth for a short time. However, the market for CSF management devices is on the period of recovery with the resumption of activities across various domains including healthcare services owing to the approval and administration of numerous COVID-19 vaccines across the globe, thereby presenting a positive future outlook for the cerebrospinal fluid management market during the forecast period.

Cerebrospinal Fluid Management Market Segment Analysis:

Cerebrospinal Fluid Management Market by Product Type (CSF Shunts & Valves, External Drainage Systems [Drainage and Monitoring Systems, Drainage-specific Systems, and CSF Drainage Catheters {Ventricular, Lumbar, and Others}], Anti-Siphon Devices, and Others), by Age Group (Adult and Pediatric), by End User (Hospitals and Specialty Clinics), and by Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product segment of the CSF management market, the CSF shunts and valves are expected to account for a significant revenue share in the market during the forecast period. This can be attributed to their applicability in the treatment of hydrocephalus as they are most commonly placed in pediatric patients for hydrocephalus/fluid space collections due to intraventricular hemorrhage or spina bifida and have significantly improved clinical outcomes associated with these conditions. Furthermore, they offer a more permanent treatment approach compared to other CSF management devices as they are intended to remain in place for life.

Additionally, the technological advancement in product development such as the development of newer stunts with an electronically (externally) programmable component that would be help avoid over-drainage of CSF may be another key factor positively influencing the demand for this product type in the CSF management market.

North America is expected to dominate the Overall Cerebrospinal Fluid Management Market:

Among all the regions, North America is estimated to account for the significant market share in the CSF management market. North America is predicted to account for the dominant market share because of the high prevalence of hydrocephalus from various reasons such as congenital hydrocephalus, brain aneurysms, traumatic brain injury among other factors, rising population of the elderly as well as high awareness among people regarding disease management and the new product launches in the region.

The North America CSF management market is witnessing an upward trend due to the rising prevalence of congenital hydrocephalus in the country among other factors. As per the data provided by the Centers for Disease Control and Prevention, each year, about 1,427 babies are born with spina bifida, or 1 in every 2,758 births in the country. Many babies born with spina bifida also develop hydrocephalus which may boost the demand for CSF management devices such as hydrocephalus shunts, eventually driving the United States CSF management market growth during the forecast period.

Additionally, according to the data (2023) provided by the Brain Aneurysm Foundation, a US-based organization, an estimated 6.5 million people in the United States have an un-ruptured brain aneurysm. The annual rate of rupture in the country is approximately 8 - 10 per 100,000 people. About 30,000 people in the United States suffer a brain aneurysm rupture each year. A brain aneurysm ruptures every 18 minutes. It has been established that blood from a torn aneurysm can result in the blockage of CSF circulation leading to fluid buildup and increased pressure on the brain ultimately causing hydrocephalus. Therefore, the increase in number of patients suffering from brain aneurysms in the country is expected to drive the demand for CSF management devices, thereby contributing in the overall growth of the CSF management market in the North American region.

The above-mentioned facts point towards the presence of diverse patient pool in the country as well as the North American region that may benefit from the utilization of CSF management. Furthermore, the well-established patient care system along with awareness among patients and caregivers regarding different types of neurosurgeries and products used is further expected to aid in the North American CSF management market growth.

Moreover, the prompt and well-established healthcare services and infrastructure further contributes to the growth of the regional CSF management market. The presence of key players in the region and supportive reimbursement programs further provide immense growth opportunities for CSF management market. Moreover, the constant focus of market players in targeting the region in product launch is further expected to aid in the growth of the North American CSF management market. For instance, in December 2019, Raumedic AG launched a new device for home use, Raumed Home ICP for intracranial pressure (ICP) monitoring in hydrocephalus patients.

Cerebrospinal Fluid Management Market Key Players:

Some of the key market players operating in the CSF management market includes Medtronic, B. Braun Melsungen AG, Neuromedex GmbH, Natus Medical Incorporated., Sophysa, Integra LifeSciences Corporation, Spiegelberg GmbH & Co. KG, Desu Medical, Polyganics, CHRISTOPH MIETHKE GMBH & CO. KG, HpBio Proteses Inc, Wellong Instruments Co., Ltd., Moller Medical GmbH, CereVasc, Inc., Anuncia Inc, RAUMEDIC AG, Vivonics Inc and others.

Recent Developmental Activities in Cerebrospinal Fluid Management Market:

In March 2022, Anuncia Inc. received the ""Breakthrough Device Designation"" for ReFlow(TM) System Mini by the US FDA. The device is to be used in the treatment of CSF disorders requiring shunting such as hydrocephalus.

In May, 2020, Aesculap, Inc. announced the launch of M.blue(TM) Hydrocephalus Valve in the United States. The device is equipped with a unique gravitational technology integrated with a fixed differential pressure unit in one valve, thereby providing a simple, position-dependent solution.

In July 2019, Integra LifeSciences Holdings Corporation acquired Arkis Biosciences Inc. thereby also acquiring a portfolio of neurosurgical devices, including the CerebroFlo external ventricular drainage (EVD) catheter with Endexo technology.

Key Takeaways from the Cerebrospinal Fluid Management Market Report Study

Market size analysis for current CSF management market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the CSF management market.

Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years

Key companies dominating the global CSF management market.

Various opportunities available for the other competitor in the CSF management market space.

What are the top performing segments in 2023? How these segments will perform in 2030.

Which is the top-performing regions and countries in the current CSF management market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for CSF management market growth in the coming future?

Target Audience who can be benefited from this Cerebrospinal Fluid Management Market Report Study

Cerebrospinal Fluid Management products providers

Research organizations and consulting companies

Cerebrospinal Fluid Management-related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in CSF management

Various End-users who want to know more about the CSF management market and latest technological developments in the CSF management market.

Frequently Asked Questions for Cerebrospinal Fluid Management Market:

1. What is a CSF Management Device?

CSF management devices are used in the treatment of CSF accumulation and leakage in events of hydrocephalus and injuries due to various reasons such as birth defects, trauma, and other causes. These include devices such as CSF shunts, dural sealants, and intracranial pressure monitoring devices among others.

2. What is the market for Global Cerebrospinal Fluid Management?

Global Cerebrospinal Fluid Management Market will grow at a CAGR of 4.78% during the forecast period from 2024 to 2030.

3. What are the drivers for Global Cerebrospinal Fluid Management Market?

The demand for CSF management is witnessing growth due to the rising number of accident and trauma cases, growing prevalence of brain tumors, increasing cases of childhood hydrocephalus, rising demand for technologically advanced products, and increasing geriatric population are expected to drive the product demand in the global CSF management market.

4. Who are the key players operating in Global Cerebrospinal Fluid Management Market?

Some of the key market players operating in the CSF management market includes Medtronic, B. Braun Melsungen AG, Neuromedex GmbH, Natus Medical Incorporated., Sophysa, Integra LifeSciences Corporation, Spiegelberg GmbH & Co. KG, Desu Medical, Polyganics, CHRISTOPH MIETHKE GMBH & CO. KG, HpBio Proteses Inc, Wellong Instruments Co., Ltd., Moller Medical GmbH, CereVasc, Inc., Anuncia Inc, RAUMEDIC AG, Vivonics Inc and others.

5. Which region has the highest share in Cerebrospinal Fluid Management market?

North America is predicted to account for the dominant market share because of the high prevalence of hydrocephalus from various reasons such as congenital hydrocephalus, brain aneurysms, traumatic brain injury among other factors, rising population of the elderly as well as high awareness among people regarding disease management and the new product launches in the region.

Table of Contents

1.Cerebrospinal Fluid Management Market Report Introduction

2.Cerebrospinal Fluid Management Market Executive Summary

• 2.1 Scope of the Study
• 2.2 Market at Glance
• 2.3 Competitive Assessment
• 2.4 Financial Benchmarking

3. Regulatory and Patent Analysis

• 3.1 The United States
• 3.2 Europe
• 3.3 Japan
• 3.4 China

4. Cerebrospinal Fluid Management Market Key Factors Analysis

• 4.1 Cerebrospinal Fluid Management Market Drivers
  • 4.1.1 Rising Prevalence of Hydrocephalus
  • 4.1.2 Rising Number of Trauma and Accident Cases
  • 4.1.3 Rising Prevalence of Brain Tumors
  • 4.1.4 Increasing Focus on Innovative Product Development
• 4.2 Cerebrospinal Fluid Management Market Restraints and Challenges
  • 4.2.1 Risks Associated with Devices
  • 4.2.2 Stringent Product Approval Process
• 4.3 Cerebrospinal Fluid Management Market Opportunities
  • 4.3.1 Development of Devices with Antimicrobial Properties
  • 4.3.2 Product Improvement in Terms of Safety

5. Cerebrospinal Fluid Management Market Porter's Five Forces Analysis

• 5.1 Bargaining Power of Suppliers
• 5.2 Bargaining Power of Consumers
• 5.3 Threat of New Entrants
• 5.4 Threat of Substitutes
• 5.5 Competitive Rivalry

6. COVID-19 Impact Analysis on Cerebrospinal Fluid Management Market

7. Cerebrospinal Fluid Management Market Layout

• 7.1 By Product Type
  • 7.1.1 CSF Shunts and Valves
  • 7.1.2 External Drainage Systems
    • 7.1.2.1 Drainage and Monitoring Systems
    • 7.1.2.2 Drainage-Specific Systems
    • 7.1.2.3 CSF Drainage Catheters
    • 7.1.2.3.1 Ventricular
    • 7.1.2.3.2 Lumbar
    • 7.1.2.3.3 Others
  • 7.1.4 Anti-Siphon Devices
  • 7.1.5 Others
• 7.2 By Age Group
  • 7.2.1 Adult
  • 7.2.2 Pediatric
• 7.3 By End User
  • 7.3.1 Hospitals
  • 7.3.2 Specialty Clinics
• 7.4 By Geography
  • 7.4.1 North America
    • 7.4.1.1 North America Cerebrospinal Fluid Management Market, by Product Type
    • 7.4.1.2 North America Cerebrospinal Fluid Management Market, by Age Group
    • 7.4.1.2 North America Cerebrospinal Fluid Management Market, by End User
    • 7.4.1.4 North America Cerebrospinal Fluid Management Market, by Country
    • 7.4.1.4.1 United States
    • 7.4.1.4.2 Canada
    • 7.4.1.4.3 Mexico
  • 7.4.2 Europe
    • 7.4.2.1 Europe Cerebrospinal Fluid Management Market, by Product Type
    • 7.4.2.2 Europe Cerebrospinal Fluid Management Market, by Age Group
    • 7.4.2.2 Europe Cerebrospinal Fluid Management Market, by End User
    • 7.4.2.4 Europe Cerebrospinal Fluid Management Market, by Country
    • 7.4.2.4.1 France
    • 7.4.2.4.2 Germany
    • 7.4.2.4.3 United Kingdom
    • 7.4.2.4.4 Italy
    • 7.4.2.4.5 Spain
    • 7.4.2.2.6 Russia
    • 7.4.2.2.7 Rest of Europe
  • 7.4.3 Asia-Pacific
    • 7.4.3.1 Asia-Pacific Cerebrospinal Fluid Management Market, by Product Type
    • 7.4.3.2 Asia-Pacific Cerebrospinal Fluid Management Market, by Age Group
    • 7.4.3.2 Asia-Pacific Cerebrospinal Fluid Management Market, by End User
    • 7.4.3.4 Asia-Pacific Cerebrospinal Fluid Management Market, by Country
    • 7.4.3.4.1 China
    • 7.4.3.4.2 Japan
    • 7.4.3.4.3 India
    • 7.4.3.4.4 Australia
    • 7.4.3.4.5 South Korea
    • 7.4.3.4.6 Rest of Asia Pacific
  • 7.4.4 Rest of the World (RoW)
    • 7.4.4.1 RoW Cerebrospinal Fluid Management Market, by Product Type
    • 7.4.4.2 RoW Cerebrospinal Fluid Management Market, by Age Group
    • 7.4.4.2 RoW Cerebrospinal Fluid Management Market, by End User
    • 7.4.4.4 RoW Cerebrospinal Fluid Management Market, by Region
    • 7.4.4.4.1 Middle East
    • 7.4.4.4.2 Africa
    • 7.4.4.4.3 South America

8. Cerebrospinal Fluid Management Market Global Company Share Analysis - Key 3-5 Companies

9. Cerebrospinal Fluid Management Market Company and Product Profiles

• 9.1 Medtronic
  • 9.1.1. Company Overview
  • 9.1.2. Company Snapshot
  • 9.1.3. Financial Overview
  • 9.1.4 Product Listing
  • 9.1.5. Entropy
• 9.2 B. Braun Melsungen AG
  • 9.2.1. Company Overview
  • 9.2.2. Company Snapshot
  • 9.2.3. Financial Overview
  • 9.2.4 Product Listing
  • 9.2.5. Entropy
• 9.3 Neuromedex GmbH
  • 9.3.1. Company Overview
  • 9.3.2. Company Snapshot
  • 9.3.3. Financial Overview
  • 9.3.4 Product Listing
  • 9.3.5. Entropy
• 9.4 Natus Medical Incorporated
  • 9.4.1. Company Overview
  • 9.4.2. Company Snapshot
  • 9.4.3. Financial Overview
  • 9.4.4 Product Listing
  • 9.4.5. Entropy
• 9.5 Sophysa
  • 9.5.1. Company Overview
  • 9.5.2. Company Snapshot
  • 9.5.3. Financial Overview
  • 9.5.4 Product Listing
  • 9.5.5. Entropy
• 9.6 Integra LifeSciences Corporation
  • 9.6.1. Company Overview
  • 9.6.2. Company Snapshot
  • 9.6.3. Financial Overview
  • 9.6.4 Product Listing
  • 9.6.5. Entropy
• 9.7 Spiegelberg GmbH & Co. KG
  • 9.7.1. Company Overview
  • 9.7.2. Company Snapshot
  • 9.7.3. Financial Overview
  • 9.7.4 Product Listing
  • 9.7.5. Entropy
• 9.8 Desu Medical
  • 9.8.1. Company Overview
  • 9.8.2. Company Snapshot
  • 9.8.3. Financial Overview
  • 9.8.4 Product Listing
  • 9.8.5. Entropy
• 9.9 Polyganics
  • 9.9.1. Company Overview
  • 9.9.2. Company Snapshot
  • 9.9.3. Financial Overview
  • 9.9.4 Product Listing
  • 9.9.5. Entropy
• 9.10 CHRISTOPH MIETHKE GMBH & CO. KG
  • 9.10.1. Company Overview
  • 9.10.2. Company Snapshot
  • 9.10.3. Financial Overview
  • 9.10.4 Product Listing
  • 9.10.5. Entropy
• 9.11 HpBio Proteses Inc
  • 9.11.1. Company Overview
  • 9.11.2. Company Snapshot
  • 9.11.3. Financial Overview
  • 9.11.4 Product Listing
  • 9.11.5. Entropy
• 9.12 Wellong Instruments Co., Ltd.
  • 9.12.1. Company Overview
  • 9.12.2. Company Snapshot
  • 9.12.3. Financial Overview
  • 9.12.4 Product Listing
  • 9.12.5. Entropy
• 9.13 Moller Medical GmbH
  • 9.13.1. Company Overview
  • 9.13.2. Company Snapshot
  • 9.13.3. Financial Overview
  • 9.13.4 Product Listing
  • 9.13.5. Entropy
• 9.14 RAUMEDIC AG
  • 9.14.1. Company Overview
  • 9.14.2. Company Snapshot
  • 9.14.3. Financial Overview
  • 9.14.4 Product Listing
  • 9.14.5. Entropy
• 9.15 Anuncia Inc
  • 9.15.1. Company Overview
  • 9.15.2. Company Snapshot
  • 9.15.3. Financial Overview
  • 9.15.4 Product Listing
  • 9.15.5. Entropy
• 9.16 Vivonics Inc
  • 9.16.1. Company Overview
  • 9.16.2. Company Snapshot
  • 9.16.3. Financial Overview
  • 9.16.4 Product Listing
  • 9.16.5. Entropy
• 9.17 CereVasc Inc
  • 9.17.1. Company Overview
  • 9.17.2. Company Snapshot
  • 9.17.3. Financial Overview
  • 9.17.4 Product Listing
  • 9.17.5. Entropy

10. KOL Views

11. Project Approach

12. About DelveInsight

13. Disclaimer & Contact Us

List of Tables

• Table 1 Competitive Analysis
• Table 2 COVID-19 Impact Analysis on Cerebrospinal Fluid Management Market
• Table 3 Cerebrospinal Fluid Management Market in Global (2021-2030)
• Table 4 Cerebrospinal Fluid Management Market in Global by Product Type (2021-2030)
• Table 5 Cerebrospinal Fluid Management Market in Global by Age Group (2021-2030)
• Table 6 Cerebrospinal Fluid Management Market in Global by End User (2021-2030)
• Table 7 Cerebrospinal Fluid Management Market in Global by Geography (2021-2030)
• Table 8 Cerebrospinal Fluid Management Market in North America (2021-2030)
• Table 9 Cerebrospinal Fluid Management Market in North America by Product Type (2021-2030)
• Table 10 Cerebrospinal Fluid Management Market in North America by Age Group (2021-2030)
• Table 11 Cerebrospinal Fluid Management Market in North America by End User (2021-2030)
• Table 12 Cerebrospinal Fluid Management Market in North America by Country (2021-2030)
• Table 13 Cerebrospinal Fluid Management Market in the US (2021-2030)
• Table 14 Cerebrospinal Fluid Management Market in Canada (2021-2030)
• Table 15 Cerebrospinal Fluid Management Market in Mexico (2021-2030)
• Table 16 Cerebrospinal Fluid Management Market in Europe (2021-2030)
• Table 17 Cerebrospinal Fluid Management Market in Europe by Product Type (2021-2030)
• Table 18 Cerebrospinal Fluid Management Market in Europe by Age Group (2021-2030)
• Table 19 Cerebrospinal Fluid Management Market in Europe by End User (2021-2030)
• Table 20 Cerebrospinal Fluid Management Market in Europe by Country (2021-2030)
• Table 21 Cerebrospinal Fluid Management Market in France (2021-2030)
• Table 22 Cerebrospinal Fluid Management Market in Germany (2021-2030)
• Table 23 Cerebrospinal Fluid Management Market in the United Kingdom (2021-2030)
• Table 24 Cerebrospinal Fluid Management Market in Italy (2021-2030)
• Table 25 Cerebrospinal Fluid Management Market in Spain (2021-2030)
• Table 26 Cerebrospinal Fluid Management Market in Russia (2021-2030)
• Table 27 Cerebrospinal Fluid Management Market in Rest of Europe (2021-2030)
• Table 28 Cerebrospinal Fluid Management Market in APAC (2021-2030)
• Table 29 Cerebrospinal Fluid Management Market in APAC by Product Type (2021-2030)
• Table 30 Cerebrospinal Fluid Management Market in APAC by Age Group (2021-2030)
• Table 31 Cerebrospinal Fluid Management Market in APAC by End User (2021-2030)
• Table 32 Cerebrospinal Fluid Management Market in APAC by Country (2021-2030)
• Table 33 Cerebrospinal Fluid Management Market in China (2021-2030)
• Table 34 Cerebrospinal Fluid Management Market in Japan (2021-2030)
• Table 35 Cerebrospinal Fluid Management Market in India (2021-2030)
• Table 36 Cerebrospinal Fluid Management Market in Australia (2021-2030)
• Table 37 Cerebrospinal Fluid Management Market in South Korea (2021-2030)
• Table 38 Cerebrospinal Fluid Management Market in Rest of APAC (2021-2030)
• Table 39 Cerebrospinal Fluid Management Market in Rest of World (2021-2030)
• Table 40 Cerebrospinal Fluid Management Market in RoW by Product Type (2021-2030)
• Table 41 Cerebrospinal Fluid Management Market in RoW by Age Group (2021-2030)
• Table 42 Cerebrospinal Fluid Management Market in RoW by End User (2021-2030)
• Table 43 Cerebrospinal Fluid Management Market in RoW by Region (2021-2030)
• Table 44 Cerebrospinal Fluid Management Market in Middle East (2021-2030)
• Table 45 Cerebrospinal Fluid Management Market in Africa (2021-2030)
• Table 46 Cerebrospinal Fluid Management Market in South America (2021-2030)

List of Figures

Figures 1 Competitive Analysis

Figures 2 COVID-19 Impact Analysis on Cerebrospinal Fluid Management Market

Figures 3 Cerebrospinal Fluid Management Market in Global (2021-2030)

Figures 4 Cerebrospinal Fluid Management Market in Global by Product Type (2021-2030)

Figures 5 Cerebrospinal Fluid Management Market in Global by Age Group (2021-2030)

Figures 6 Cerebrospinal Fluid Management Market in Global by End User (2021-2030)

Figures 7 Cerebrospinal Fluid Management Market in Global by Geography (2021-2030)

Figures 8 Cerebrospinal Fluid Management Market in North America (2021-2030)

Figures 9 Cerebrospinal Fluid Management Market in North America by Product Type (2021-2030)

Figures 10 Cerebrospinal Fluid Management Market in North America by Age Group (2021-2030)

Figures 11 Cerebrospinal Fluid Management Market in North America by End User (2021-2030)

Figures 12 Cerebrospinal Fluid Management Market in North America by Country (2021-2030)

Figures 13 Cerebrospinal Fluid Management Market in the US (2021-2030)

Figures 14 Cerebrospinal Fluid Management Market in Canada (2021-2030)

Figures 15 Cerebrospinal Fluid Management Market in Mexico (2021-2030)

Figures 16 Cerebrospinal Fluid Management Market in Europe (2021-2030)

Figures 17 Cerebrospinal Fluid Management Market in Europe by Product Type (2021-2030)

Figures 18 Cerebrospinal Fluid Management Market in Europe by Age Group (2021-2030)

Figures 19 Cerebrospinal Fluid Management Market in Europe by End User (2021-2030)

Figures 20 Cerebrospinal Fluid Management Market in Europe by Country (2021-2030)

Figures 21 Cerebrospinal Fluid Management Market in France (2021-2030)

Figures 22 Cerebrospinal Fluid Management Market in Germany (2021-2030)

Figures 23 Cerebrospinal Fluid Management Market in the United Kingdom (2021-2030)

Figures 24 Cerebrospinal Fluid Management Market in Italy (2021-2030)

Figures 25 Cerebrospinal Fluid Management Market in Spain (2021-2030)

Figures 26 Cerebrospinal Fluid Management Market in Russia (2021-2030)

Figures 27 Cerebrospinal Fluid Management Market in Rest of Europe (2021-2030)

Figures 28 Cerebrospinal Fluid Management Market in APAC (2021-2030)

Figures 29 Cerebrospinal Fluid Management Market in APAC by Product Type (2021-2030)

Figures 30 Cerebrospinal Fluid Management Market in APAC by Age Group (2021-2030)

Figures 31 Cerebrospinal Fluid Management Market in APAC by End User (2021-2030)

Figures 32 Cerebrospinal Fluid Management Market in APAC by Country (2021-2030)

Figures 33 Cerebrospinal Fluid Management Market in China (2021-2030)

Figures 34 Cerebrospinal Fluid Management Market in Japan (2021-2030)

Figures 35 Cerebrospinal Fluid Management Market in India (2021-2030)

Figures 36 Cerebrospinal Fluid Management Market in Australia (2021-2030)

Figures 37 Cerebrospinal Fluid Management Market in South Korea (2021-2030)

Figures 38 Cerebrospinal Fluid Management Market in Rest of APAC (2021-2030)

Figures 39 Cerebrospinal Fluid Management Market in Rest of World (2021-2030)

Figures 40 Cerebrospinal Fluid Management Market in RoW by Product Type (2021-2030)

Figures 41 Cerebrospinal Fluid Management Market in RoW by Age Group (2021-2030)

Figures 42 Cerebrospinal Fluid Management Market in RoW by End User (2021-2030)

Figures 43 Cerebrospinal Fluid Management Market in RoW by Region (2021-2030)

Figures 44 Cerebrospinal Fluid Management Market in Middle East (2021-2030)

Figures 45 Cerebrospinal Fluid Management Market in Africa (2021-2030)

Figures 46 Cerebrospinal Fluid Management Market in South America (2021-2030)

Figures 47 Market Drivers

Figures 48 Market Barriers

Figures 49 Marker Opportunities

Figures 50 PORTER'S Five Force Analysis